{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:05:51Z","timestamp":1783933551590,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Objective: Residency programs in the United States lack the necessary training for physicians to confidently and competently inject botulinum neurotoxin (BoNT) and manage complex spasticity patients. This creates an unmet need for spasticity patients who could benefit from BoNT injections. This study measured the impact of additional BoNT injection and spasticity management training on post-residency medical practice. Design: Graduates from our Physical Medicine and Rehabilitation residency from 2008 to 2024 were surveyed. Responses were collected from physicians who had residency BoNT injection and spasticity management training (RT) and compared to fellowship BoNT injection and comprehensive spasticity management training (FT). Results: 15 RT and 14 FT physicians completed the survey and were evaluated using descriptive statistics. Spasticity and dystonia treatments comprised an average of 10% of the RT and 62% of the FT clinical practice. BoNT injections involved 5% of the RT practice and 52% of the FT practice. Conclusion: Disabling spasticity is undertreated in this country, partly due to a shortage of training programs for physicians to become skilled and confident at injecting BoNT and comprehensive spasticity management. FT programs can help meet this unmet need by increasing the number of physicians who can provide specialized BoNT injections and spasticity management.<\/jats:p>","DOI":"10.3390\/toxins18070301","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:31Z","timestamp":1783929931000},"page":"301","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Benefits of Advanced Botulinum Neurotoxin Injection Training from a Spasticity Management Fellowship"],"prefix":"10.3390","volume":"18","author":[{"given":"John","family":"McGuire","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Goodfriend","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Golus","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1420-3090","authenticated-orcid":false,"given":"Whitney","family":"Morelli","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Elizabeth S.","family":"Nelson-Biersach","sequence":"additional","affiliation":[{"name":"International Rehabilitation Forum, Middlebury, VT 05753, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3835-0498","authenticated-orcid":false,"given":"Nicholas","family":"Ketchum","sequence":"additional","affiliation":[{"name":"Center for Neurological Disorders, Greenfield, WI 53228, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/pmrj.13211","article-title":"AAPM&R consensus guidance on spasticity assessment and management","volume":"16","author":"Raghavan","year":"2024","journal-title":"PM R"},{"key":"ref_2","first-page":"133","article-title":"Optimal management for people with severe spasticity","volume":"2","author":"Shilt","year":"2012","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jamda.2020.01.005","article-title":"Prevalence of Spasticity in Nursing Home Residents","volume":"21","author":"Gill","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1212\/WNL.0000000000203536","article-title":"Adherence to Botulinumtoxin Treatment: A 2-year Retrospective Claims Database Analysis (P12-11.008)","volume":"100","author":"Simpson","year":"2023","journal-title":"Neurology"},{"key":"ref_5","unstructured":"Lamontagne, A., and Darhi, Y. (2021). Analysis of U.S. Commercial Claims to Understand Patient Treatment Pathways in Spasticity. PM&R."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/pmrj.13106","article-title":"Multidisciplinary collaborative consensus statement on the barriers and solutions to care access, patient and caregiver support, and clinical capacity and capability for patients with spasticity","volume":"16","author":"Patel","year":"2024","journal-title":"PM&R"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4103\/2349-7904.347807","article-title":"Module 1: Pathophysiology and Assessment of Spasticity; Goal Setting","volume":"5","author":"Escaldi","year":"2022","journal-title":"J. Int. Soc. Phys. Rehabil. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.clinph.2014.11.005","article-title":"Contributions of motoneuron hyperexcitability to clinical spasticity in hemispheric stroke survivors","volume":"126","author":"Hu","year":"2015","journal-title":"Clin. Neurophysiol."},{"key":"ref_9","first-page":"279175","article-title":"Clinical Understanding of Spasticity: Implications for Practice","volume":"2014","author":"Bhimani","year":"2014","journal-title":"Rehabil. Res. Pract."},{"key":"ref_10","first-page":"697","article-title":"Demystifying spasticity in primary care","volume":"65","author":"Milligan","year":"2019","journal-title":"Can. Fam. Physician"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1161\/STROKEAHA.111.639831","article-title":"Poststroke Spasticity Management","volume":"43","author":"Francisco","year":"2012","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/EOR-2024-0156","article-title":"Current techniques for the treatment of spasticity and their effectiveness","volume":"10","author":"Li","year":"2025","journal-title":"EFORT Open Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hcl.2018.06.003","article-title":"Nonsurgical Treatment Options for Upper Limb Spasticity","volume":"34","author":"Black","year":"2018","journal-title":"Hand Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/1658-354X.121087","article-title":"Spasticity\u2013Pathogenesis, prevention and treatment strategies","volume":"7","author":"Ghai","year":"2013","journal-title":"Saudi J. Anaesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jpbs.jpbs_556_22","article-title":"Oral Antispasticity Drugs and Non-Progressive Neurological Diseases: A Meta-Analysis on Safety and Efficacy","volume":"15","author":"Alshahrani","year":"2023","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Raciti, L., Raciti, G., Ammendolia, A., de Sire, A., Onesta, M.P., and Calabr\u00f2, R.S. (2024). Improving Spasticity by Using Botulin Toxin: An Overview Focusing on Combined Approaches. Brain Sci., 14.","DOI":"10.3390\/brainsci14070631"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.4103\/2349-7904.347808","article-title":"Module 2: Nonsurgical Management of Spasticity","volume":"5","author":"Reebye","year":"2022","journal-title":"J. Int. Soc. Phys. Rehabil. Med."},{"key":"ref_18","first-page":"27536351241285200","article-title":"Cryoneurolysis as a Novel Treatment for Spasticity, Associated Pain and Presumed Contracture","volume":"13","author":"Winston","year":"2024","journal-title":"Adv. Rehabil. Sci. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pmr.2026.01.009","article-title":"Emerging Role of Cryoneurolysis in Spasticity Management: A Narrative Review","volume":"37","author":"Boissonnault","year":"2026","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11832-013-0512-9","article-title":"Surgical management of spasticity","volume":"7","author":"Roberts","year":"2013","journal-title":"J. Child. Orthop."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20542704241278544","DOI":"10.1177\/20542704241278544","article-title":"Surgical reconstruction for spasticity and contracture: An underutilised rehabilitative strategy of adult stroke","volume":"15","author":"Chung","year":"2024","journal-title":"JRSM Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.4103\/2349-7904.347809","article-title":"Module 3: Surgical Management of Spasticity","volume":"5","author":"Gross","year":"2022","journal-title":"J. Int. Soc. Phys. Rehabil. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mds.30062","article-title":"Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations","volume":"40","author":"Gal","year":"2025","journal-title":"Mov. Disord."},{"key":"ref_24","first-page":"2738","article-title":"Clinical Spasticity Assessment Using the Modified Tardieu Scale Does Not Reflect Joint Angular Velocity or Range of Motion During Walking: Assessment Tool Implications","volume":"53","author":"Banky","year":"2020","journal-title":"J. Rehabil. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Suputtitada, A., Chatromyen, S., Chen, C.P.C., and Simpson, D.M. (2024). Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review. Toxins, 16.","DOI":"10.3390\/toxins16020098"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chang, W.H. (2022). Personalized Approaches to Stroke: One Step Forward for Functional Recovery of Stroke Patients. J. Pers. Med., 12.","DOI":"10.3390\/jpm12050822"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.4103\/2349-7904.347810","article-title":"Module 4: Optimizing Outcomes in Spasticity Treatment","volume":"5","author":"Ketchum","year":"2022","journal-title":"J. Int. Soc. Phys. Rehabil. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2929.2005.02341.x","article-title":"Entrustability of professional activities and competency-based training","volume":"39","year":"2005","journal-title":"Med. Educ."},{"key":"ref_29","unstructured":"Accreditation Council for Graduate Medical Education (ACGME) (2025). ACGME Program Requirements for Graduate Medical Education in Physical Medicine and Rehabilitation, Accreditation Council for Graduate Medical Education (ACGME)."},{"key":"ref_30","unstructured":"(2025, August 20). STEP Interventional Spasticity Certificate Program. Available online: https:\/\/www.aapmr.org\/education\/step-certificate-programs\/step-interventional-spasticity-certificate-program."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dreyfus, S.E., and Dreyfus, H.L. (1980). A Five-Stage Model of the Mental Activities Involved in Directed Skill Acquisition, Defense Technical Information Center.","DOI":"10.21236\/ADA084551"},{"key":"ref_32","unstructured":"National Resident Matching Program (2025). Results and Data: 2025 Main Residency Match, NRMP. Available online: https:\/\/www.nrmp.org\/match-data\/2025\/05\/results-and-data-2025-main-residency-match\/."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/301\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:16:25Z","timestamp":1783930585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070301"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070301","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}